VOYA Investment Management
CRNX icon

VOYA Investment Management’s Crinetics Pharmaceuticals CRNX Stock Holding History

VOYA Investment Management’s Portfolio CRNX Stock Details CRNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.1M Buy
306,039
+4,038
+1% +$180K 0.01% 589
2025
Q4 		$14.1M Buy
302,001
+267,307
+770% +$11.9M 0.01% 575
2025
Q3 		$1.45M Sell
34,694
-14,263
-29% -$456K ﹤0.01% 1356
2025
Q2 		$1.41M Sell
48,957
-309,578
-86% -$9.56M ﹤0.01% 1433
2025
Q1 		$12M Sell
358,535
-30,685
-8% -$1.15M 0.01% 680
2024
Q4 		$19.9M Buy
389,220
+582
+0.1% +$32.6K 0.02% 547
2024
Q3 		$19.9M Buy
388,638
+151,865
+64% +$7.83M 0.02% 549
2024
Q2 		$10.6M Buy
236,773
+187,515
+381% +$8.66M 0.01% 739
2024
Q1 		$2.31M Sell
49,258
-4,348
-8% -$170K ﹤0.01% 1302
2023
Q4 		$1.91M Buy
53,606
+727
+1% +$22.3K ﹤0.01% 1385
2023
Q3 		$1.57M Buy
52,879
+31,371
+146% +$646K ﹤0.01% 1435
2023
Q2 		$388K Buy
21,508
+902
+4% +$18K ﹤0.01% 2222
2023
Q1 		$331K Hold
20,606
– – ﹤0.01% 2280
2022
Q4 		$377K Hold
20,606
– – ﹤0.01% 2179
2022
Q3 		$405K Buy
20,606
+746
+4% +$15.2K ﹤0.01% 2159
2022
Q2 		$370K Buy
19,860
+2,356
+13% +$47K ﹤0.01% 2027
2022
Q1 		$384K Buy
17,504
+2,132
+14% +$43.2K ﹤0.01% 2055
2021
Q4 		$437K Buy
15,372
+1,260
+9% +$31.1K ﹤0.01% 2100
2021
Q3 		$297K Hold
14,112
– – ﹤0.01% 2353
2021
Q2 		$266K Buy
14,112
+852
+6% +$15K ﹤0.01% 2433
2021
Q1 		$203K Buy
13,260
+748
+6% +$11.6K ﹤0.01% 2542
2020
Q4 		$177K Buy
+12,512
New +$174K ﹤0.01% 2460

Other funds holding CRNX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

VOYA Investment Management's CRNX Position: Q1 2026 in Review

VOYA Investment Management increased its Crinetics Pharmaceuticals (CRNX) stake by 1.3% in Q1 2026, buying an estimated $180K and bringing the position to 306,039 shares worth $11.1M. The position accounts for 0.01% of the portfolio, ranked #589.

VOYA Investment Management first reported a position in CRNX in Q4 2020 and has held it in 22 quarters since. The position peaked at $19.9M in Q4 2024. 243 funds tracked by Wall St. Rank hold CRNX as of Q1 2026.

  • VOYA Investment Management held 306,039 shares of Crinetics Pharmaceuticals worth $11.1M as of Q1 2026.
  • VOYA Investment Management bought 4,038 Crinetics Pharmaceuticals shares in Q1 2026, an estimated $180K.
  • Crinetics Pharmaceuticals made up 0.01% of VOYA Investment Management's portfolio in Q1 2026, its #589 holding.
  • VOYA Investment Management first reported a position in Crinetics Pharmaceuticals in Q4 2020 and has held it in 22 quarters since.
  • VOYA Investment Management's Crinetics Pharmaceuticals position peaked at $19.9M in Q4 2024.
  • 243 funds tracked by Wall St. Rank held Crinetics Pharmaceuticals as of Q1 2026.

Based on VOYA Investment Management's 13F filing for Q1 2026, filed 12 May 2026.